- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Noggin antibody [EPR26109-174] (AB326564)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized A-172 (human brain glioblastoma cell) untreated and A-172 treated with 300 ng/ml BFA for 24 hours cells labelling Noggin with ab326564 at 1/50 (10.52 µg/ml) dilution , followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).
Confocal image showing increased cytoplasmic staining in A-172 cells (shown in green) treated with 300 ng/ml BFA (Brefeldin A) for 24 hours. The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Magenta). The Nuclear counterstain was DAPI (Blue).
- WB
Lab
Western blot - Anti-Noggin antibody [EPR26109-174] (AB326564)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : HepG2.
The identity of the higher MW band at approximately 37 kDa (in lane 3) is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).
All lanes:
Western blot - Anti-Noggin antibody [EPR26109-174] (ab326564) at 1/1000 dilution
Lane 1:
Untreated A-172 (human brain glioblastoma cell) whole cell lysate at 50 µg
Lane 2:
A-172 treated with 300ng/ml BFA for 24h whole cell lysate at 50 µg
Lane 3:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 50 µg
Lane 4:
Untreated RD (human muscle multinucleated spindle-shaped cell) whole cell lysate at 50 µg
Lane 5:
RD treated with 300ng/ml BFA for 24h whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 25 kDa,36 kDa
false
Exposure time: 59s
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com